Hiroki Ito
Download the ICS Branding Pack
Open Discussion Session 32 On Demand Prostate Clinical / Surgical 498 Efficacy of second generation bipolar transurethral electro vaporization of the prostate (TUVP) for large benign prostatic enlargement (BPE) with prostate volume ≥100ml
Podium Short Oral Session 13 Male Incontinence 246 Severity ranges of the International Prostate Symptom Score (IPSS); proposal to adjust the banding using baseline data of a large randomised trial in secondary care
Podium Short Oral Session 5 Basic Science: Pharmacology 43 Sildenafil, a Phosphodiesterase Type 5 Inhibitor, augments bladder afferent activity in mouse.
Podium Short Oral Session 37 Neurourology 727 Effects of Sildenafil on bladder and urethral function in a novel voiding mouse model: The decerebrate arterially-perfused mouse (DAPM) preparation
Podium Poster Session 41 Neurophysiology and Bladder Dysfunction 647 LONG-TERM CALORIE RESTRICTION PROTECTS AGAINST AGE-RELATED OXIDATIVE AND FIBROTIC CHANGES IN THE RAT BLADDER
Podium Poster Session 5 Basic Science 2: Sensory Pathways 28 AGE-RELATED CHANGES IN DETRUSOR PROPERTIES AND GENE EXPRESSION IN THE BLADDER AND DORSAL ROOT GANGLION OF THE RAT AND PREVENTATIVE EFFECT OF LOW CALORIC DIET AGAINST THESE CHANGES
Podium Poster Session 5 Basic Science 2: Sensory Pathways 30 EFFECTS OF TRPM8 CHANNELS’ INHIBITION ON CONCIOUS CYSTOMETRY AND SINGLE-UNIT MECHANOSENSITIVE BLADDER AFFERENT ACTIVITIES IN NOVEL EX VIVO MODEL OF THE RAT
ICS Editorial Board Member
Dr Hiroki Ito declared on the Tuesday 9th January 2024 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
Continence Editorial Board
Editorial Board Member